Alkermes Announces the Appointment of Emily Peterson Alva to its Board of Directors
DUBLIN, May 20, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Emily Peterson Alva, to the company s Board of Directors ( Board ). Emily Peterson Alva is an experienced public company board member and a financial, strategic and business advisor to growth companies. A former Lazard M&A Partner with more than 15 years of investment banking experience, Ms. Alva brings significant experience navigating complex strategic, transactional and governance matters for public companies across many sectors including specific expertise in healthcare and pharmaceuticals. I am delighted to welcome Emily to Alkermes Board of Directors and look forward to her insights and perspectives as we focus our efforts on high return-on-investment opportunities that are consistent with our long-term growth strategy, said Richard Pops, Chief Executive Officer and
Alkermes Announces Agreement with Sarissa Capital
Grants Sarissa Right to Designate Director to Alkermes Board
DUBLIN, April 30, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced that it has reached an agreement with Sarissa Capital Management LP ( Sarissa Capital ), a beneficial owner of approximately 5% of the company s outstanding ordinary shares, pursuant to which Sarissa Capital has the right to designate a director to the company s Board of Directors (the Board ).
This agreement follows constructive dialogue between the parties related to the company s strategic priorities and ongoing Board refreshment efforts. Alkermes initiated a robust board refreshment program two years ago and has since added four new independent directors to the Board.
CONTENT: Press Release
DUBLIN, April 29, 2021 /3BL Media/ Myrelationshipwithalcohol.com, a new website sponsored by Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), recently went live to offer education about alcohol dependence. Alcohol dependence is a treatable disease, but the belief that it is a moral or personal failing may prevent individuals from seeking help.
1 This new resource launches at a time when a growing number of people may be re-evaluating their drinking patterns. As one of the few companies working in this disease area, we felt compelled to develop a resource to help people better understand alcohol dependence, remarked Blair Jackson, Executive Vice President, Chief Operating Officer of Alkermes. Alcohol dependence is a medical condition affecting millions of Americans. Despite its prevalence, understanding of the disease itself and awareness of approved treatment options that exist remain low. Our aim is to provide people who may be liv
/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2021. "Our first quarter results reflect solid execution.
- Two Posters to Include Data Updates From ARTISTRY-1 and ARTISTRY-2 Clinical Trials Evaluating Immuno-Oncology Candidate Nemvaleukin Alfa - DUBLIN, April 28, 2021 /PRNewswire/ Alkermes